| GTO ID | GTC1413 |
| Trial ID | NCT01531244 |
| Disease | Melanoma |
| Therapy | Gene transfer |
| Treatment | CRAd 3/5-delta |
| Co-treatment | dactinomycin|melphalan |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | A Phase I/II Study of Isolated Limb Infusion and Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma |
| Year | 2012 |
| Country | United States |
| Company sponsor | Washington University School of Medicine |
| Other ID(s) | 11-X335 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||
|
|||||